Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oberg

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Bone Marrow Transplantation|August 1, 1991
Renal function after autologous bone marrow transplantationG Lönnerholm, K Carlson, L E Bratteby, et al.
British Journal of Cancer|July 1, 1994
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumoursH Fridborg, B Jonsson, P Nygren, et al.
Lakartidningen|November 10, 1993
[Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients]H Hagberg, A Berglund, K Carlson, et al.
Bone Marrow Transplantation|July 1, 1994
Pulmonary function after autologous bone marrow transplantation in childrenJ Arvidson, L E Bratteby, K Carlson, et al.
Leukemia & Lymphoma|January 1, 1992
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, M Björeman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1992
Reduced regional cerebral blood flow in Huntington's disease studied by SPECTS G Hasselbalch, G Oberg, S A Sørensen, et al.
Bone Marrow Transplantation|January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-groupB Simonsson, G Oberg, A Killander, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacologyM Hassan, G Oberg, A N Bekassy, et al.
Journal of Internal Medicine|April 1, 1992
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemiasJ Palmblad, B Lönnqvist, B Carlsson, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, A Killander, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Bone Marrow Transplantation|August 1, 1991
Renal function after autologous bone marrow transplantationG Lönnerholm, K Carlson, L E Bratteby, et al.
British Journal of Cancer|July 1, 1994
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumoursH Fridborg, B Jonsson, P Nygren, et al.
Lakartidningen|November 10, 1993
[Malignant lymphoma. Experiences with autologous bone marrow transplantation in 50 patients]H Hagberg, A Berglund, K Carlson, et al.
Bone Marrow Transplantation|July 1, 1994
Pulmonary function after autologous bone marrow transplantation in childrenJ Arvidson, L E Bratteby, K Carlson, et al.
Leukemia & Lymphoma|January 1, 1992
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, M Björeman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1992
Reduced regional cerebral blood flow in Huntington's disease studied by SPECTS G Hasselbalch, G Oberg, S A Sørensen, et al.
Bone Marrow Transplantation|January 1, 1994
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-groupB Simonsson, G Oberg, A Killander, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacologyM Hassan, G Oberg, A N Bekassy, et al.
Journal of Internal Medicine|April 1, 1992
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemiasJ Palmblad, B Lönnqvist, B Carlsson, et al.
Stem Cells (Dayton, Ohio)|October 1, 1993
Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemiaB Simonsson, G Oberg, A Killander, et al.
Pageof 11